Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #50,051 to #50,100.
- Monocytic leukemia future or investigational therapies (3 revisions)
- Monocytic leukemia historical perspective (3 revisions)
- Monocytic leukemia other imaging findings (3 revisions)
- Monocytic leukemia pathophysiology (3 revisions)
- Monocytic leukemia secondary prevention (3 revisions)
- Monocytic leukemia staging (3 revisions)
- Monocytic leukemia surgery (3 revisions)
- Monogastric (3 revisions)
- Monosaccharide (3 revisions)
- Monosomy (3 revisions)
- Mood congruence (3 revisions)
- Mood disorder (3 revisions)
- Mooren's ulcer (3 revisions)
- Morn repeat containing 1 (3 revisions)
- Morniflumate (3 revisions)
- Morning care (3 revisions)
- Morning headaches (3 revisions)
- Morning sickness (3 revisions)
- Morning sickness (patient information) (3 revisions)
- Morphine (3 revisions)
- Morphine (rectal) (3 revisions)
- Morphine detailed information (3 revisions)
- Morton's neuroma case study one (3 revisions)
- Morton's neuroma echocardiography or ultrasound (3 revisions)
- Mosapramine (3 revisions)
- Mosunetuzumab-axgb (3 revisions)
- Mothers against decapentaplegic homolog 3 (3 revisions)
- Mothers against decapentaplegic homolog 7 (3 revisions)
- Motif ten element gene transcriptions (3 revisions)
- Motilin receptor (3 revisions)
- Motion sickness epidemiology and demographics (3 revisions)
- Motion sickness historical perspective (3 revisions)
- Motor protein (3 revisions)
- Motretinide (3 revisions)
- Mounier-Kuhn syndrome (3 revisions)
- Movement disorder (3 revisions)
- Moxifloxacin (3 revisions)
- Moxifloxacin (ophthalmic) (3 revisions)
- Moxifloxacin dosage and administration (3 revisions)
- Moxonidine (3 revisions)
- Mu hemoglobin (3 revisions)
- Mucin 7 (3 revisions)
- Mucinous cystadenocarcinoma case study one (3 revisions)
- Mucinous cystadenocarcinoma cost-effectiveness of therapy (3 revisions)
- Mucinous cystadenocarcinoma electrocardiogram (3 revisions)
- Mucinous cystadenocarcinoma future or investigational therapies (3 revisions)
- Mucinous cystadenocarcinoma laboratory findings (3 revisions)
- Mucinous cystadenocarcinoma laboratory tests (3 revisions)
- Mucinous cystadenocarcinoma primary prevention (3 revisions)
- Mucinous cystadenocarcinoma secondary prevention (3 revisions)